References
- 1. Siegel R. Cancer statistics, A cancer journal for Clinicians, 2013, 63 11-30.
- 2. Tam WBD. A novel gene activated by proviral insertions in avian leukosis virus – induced lymphomas is likely to function through its noncoding RNA. Moll Cell Biol, 1997, 17: 1490-502.
- 3. Kato T, Fujita Y, Nakane K et al. Ets1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-re-fractory pc3 prostate cancer cells by up-regulating mdr1 and mmp9 expression. Biochem Biphys Res Commun, 2012, 417:966-71.
- 4. Mitchell PS, Parkin RK, Kroh EM et al. Pogosova-Agadjanyan EL, Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA, 2008, 105:10513-8.
- 5. Lagos-Quintana M, Rauhut R, Yalcin A, Identification of tissue-specific MicroRNAs from mouse. Curr. Biol., 2002, 12, No. 9, 735-739.
- 6. Lin J, Cao Q, Zhang J., MicroRNA expression patterns in indeterminate inflammatory bowel disease. Mod. Pathol., 2013, 26, No. 1, 148-154.
- 7. Jun-jie YU, Xia Shu-jie, Novel role of microRNAs in prostate cancer. Chin. Med. J., 2013, 126, No. 15, 2960-4.
- 8. Srivastava S.K., Bhhardwaj A., Singh S. and Arora. S. Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance., Carcinogenesis, pp. 33:1149-57, 2012.
- 9. Todorova K, Metodiev V M, Metodieva G et al. miR-204 is disregulated in metastatic prostate cancer in vitro. Molecular Carcinogenesis, 2015, 55 (2): 131-47.
- 10. Todorova K, Zasheva D, Kanev K, Hayrabedyan S. miR-204 shifts the epithelial to mesenchymal transition in concert with the transcription factors RUNX2, ETS1 and c-MYB in prostate cancer cell line model. Journal of Cancer Research, 2014, 2014, Article ID 840906, 14.